Trials / Completed
CompletedNCT01039584
A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations
A Randomized Study Evaluating the Therapeutic Equivalence and Safety of Butoconazole Nitrate Vaginal Cream, 2% and Gynazole 1 (Butoconazole Nitrate) Vaginal Cream, 2%, Against a Vehicle Control in the Treatment of Vulvovaginal Candidiasis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 611 (actual)
- Sponsor
- Padagis LLC · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This was a study that compared the efficacy and safety of a generic butoconazole nitrate vaginal cream, 2% to Gynazole-1 (butoconazole nitrate) Vaginal Cream, 2% in the treatment of vulvovaginal candidiasis caused by Candida species.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Butoconazole Nitrate Vaginal Cream | vaginal cream |
| DRUG | Placebo | vaginal cream |
| DRUG | Gynazole 1 vaginal cream | vaginal cream |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-09-01
- Completion
- 2009-12-01
- First posted
- 2009-12-25
- Last updated
- 2023-07-12
- Results posted
- 2013-01-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01039584. Inclusion in this directory is not an endorsement.